Author Loeffler, Markus
-
2006 | Conference Abstract
CHOP/CHOEP-14 followed by consolidation with alemtuzumab in untreated aggressive T-cell lymphomas (DSHNHL 2003-1): Feasibility and toxicity of a phase II trial of the German High Grade Non-Hodgkin's Lymphoma Group DSHNHL.
Truemper, L. H.; Hohloch, K.; Kloess, M.; Duehrsen, U.; Eimermacher, H.; Haas, A. & Aldaoud, A. et al. (2006)
Journal of Clinical Oncology, 24(18) 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, Atlanta, GA.
Alexandria: Amer Soc Clinical Oncology.
Details WoS
-
2006 | Journal Article
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Hummel, M.; Bentink, S.; Berger, H.; Klapper, W.; Wessendorf, S.; Barth, T. F. E. & Bernd, H. W. et al. (2006)
New England Journal of Medicine, 354(23) pp. 2419-2430. DOI: https://doi.org/10.1056/NEJMoa055351
Details DOI PMID PMC WoS
-
2006 | Journal Article
Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (MegaCHOEP) and autologous stem cell transplantation - Early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma
Schmitz, N.; Kloess, M.; Reiser, M.; Berdel, W. E.; Metzner, B.; Dorken, B. & Kneba, M. et al. (2006)
Cancer, 106(1) pp. 136-145. DOI: https://doi.org/10.1002/cncr.21588
Details DOI PMID PMC WoS
-
2006 | Journal Article
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
Pfreundschuh, M.; Truemper, L. H.; Osterborg, A.; Pettengell, R.; Trneny, M.; Imrie, K. & Ma, D. et al. (2006)
The Lancet Oncology, 7(5) pp. 379-391. DOI: https://doi.org/10.1016/S1470-2045(06)70664-7
Details DOI PMID PMC WoS
-
2007 | Conference Abstract
The ventilation strageties influence outcome in patients with severe sepsis - results from a national prospective multicenter study
Schaedler, D.; Schmitz, G.; Engel, C.; Bogatsch, H.; Frerichs, I.; Kuhlen, R. & Quintel, M. et al. (2007)
Infection, 35
Munich: Urban & Vogel.
Details WoS
-
2007 | Conference Abstract
Final analysis of phase II study of CHOP/CHOEP-14 followed by consolidation with alemtuzumab in untreated aggressive T-cell lymphomas (DSHNHL 2003-1)
Binder, C.; Zielert, M.; Loeffler, M.; Pfreundschuli, M.; Schmitz, N.; Duehrsen, U. & Eimermacher, H. et al. (2007)
Blood, 110(11) pp. 1005A-1006A. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA.
Washington: Amer Soc Hematology.
Details WoS
-
2007 | Journal Article
Prevalence and natural history of heart failure in outpatient HIV-infected subjects: Rationale and design of the HIV-heart study
Neumann, T.; Esser, S.; Potthoff, A.; Pankuweit, S.; Neumann, A.; Breuckmann, F. & Neuhaus, K. et al. (2007)
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 12(6) pp. 243-248.
Details PMID PMC WoS
-
2007 | Journal Article
The interleukin-10 gene promoter polymorphism - 1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma
Kube, D.; Hua, T.-D.; Kloess, M.; Kulle, B.; Brockmoeller, J.; Wojnowski, L. & Loeffler, M. et al. (2007)
Genes and Immunity, 8(2) pp. 164-167. DOI: https://doi.org/10.1038/sj.gene.6364364
Details DOI PMID PMC WoS
-
2007 | Journal Article
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
Engel, C.; Brunkhorst, F. M.; Bone, H.-G.; Brunkhorst, R.; Gerlach, H.; Grond, S. & Gruendling, M. et al. (2007)
Intensive Care Medicine, 33(4) pp. 606-618. DOI: https://doi.org/10.1007/s00134-006-0517-7
Details DOI PMID PMC WoS
-
2008 | Conference Abstract
Response adapted assignment of the number of chemotherapy cycles for the treatment of patients with Diffuse Large B-cell Lymphoma (DLBCL) is not justified: Results of the RICOVER-60 trial of the German high-grade non-hodgkin lymphoma study group (DSHNHL)
Schubert, J.; Ziepert, M.; Lengfelder, E.; Mohren, M.; Peter, N.; Reiser, M. & Clemens, M. et al. (2008)
Onkologie, 31
Basel: Karger.
Details WoS
-
2008 | Conference Abstract
Conserved oncogenic module activation patterns (COMAPS) identify biologically homogeneous groups of diffuse large B-cell lymphomas and clearly define Burkitt lymphoma
Bentink, S.; Wessendorf, S.; Schwaenen, C.; Rosolowski, M.; Klapper, W.; Rosenwald, A. & Ott, G. et al. (2008)
Annals of Oncology, 19 10th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS
-
2008 | Conference Abstract
T-cell lymphomas in studies of the German high-grade NHL study group (DSHNHL)
Schmitz, N.; Ziepert, M.; Nickelsen, M.; Truemper, L. H.; Glass, B.; Loeffler, M. & Ho, A. D. et al. (2008)
Annals of Oncology, 19 10th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS
-
2008 | Conference Abstract
Different subtypes of aggressive B cell lymphomas share an epigenetic signature enriched for polycomb targets in stem cells
Martin-Subero, J. I.; Kreuz, M.; Bibikova, M.; Bentink, S.; Klapper, W.; Wickham-Garcia, E. & Rosolowski, M. et al. (2008)
Annals of Oncology, 19 10th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Details WoS
-
2008 | Journal Article
Practice and perception - A nationwide survey of therapy habits in sepsis
Brunkhorst, F. M.; Engel, C.; Ragaller, M.; Welte, T.; Rossaint, R.; Gerlach, H. & Mayer, K. et al. (2008)
Critical Care Medicine, 36(10) pp. 2719-2725. DOI: https://doi.org/10.1097/CCM.0b013e318186b6f3
Details DOI PMID PMC WoS
-
2008 | Journal Article
Pathway activation patterns in diffuse large B-cell lymphomas
Bentink, S.; Wessendorf, S.; Schwaenen, C.; Rosolowski, M.; Klapper, W.; Rosenwald, A. & Ott, G. et al. (2008)
Leukemia, 22(9) pp. 1746-1754. DOI: https://doi.org/10.1038/leu.2008.166
Details DOI PMID PMC WoS
-
2008 | Journal Article
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials
Klapper, W.; Szczepanowski, M.; Burkhardt, B.; Berger, H.; Rosolowski, M.; Bentink, S. & Schwaenen, C. et al. (2008)
Blood, 112(4) pp. 1374-1381. DOI: https://doi.org/10.1182/blood-2008-01-136465
Details DOI PMID PMC WoS
-
2008 | Journal Article | Letter Note
Study protocol of the VISEP-Study. Answer of the SepNet-Study group
Reinhart, K.; Brunkhorst, F. M.; Engel, C.; Bloos, F.; Meier-Hellmann, A.; Ragaller, M. & Weiler, N. et al. (2008)
Der Anaesthesist, 57(7) pp. 723-728. DOI: https://doi.org/10.1007/s00101-008-1391-1
Details DOI PMID PMC WoS
-
2008 | Journal Article
Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: An exploratory study
Kube, D.; Hua, T.-D.; von Bonin, F.; Schoof, N.; Zeynalova, S.; Kloess, M. & Gocht, D. et al. (2008)
Clinical Cancer Research, 14(12) pp. 3777-3784. DOI: https://doi.org/10.1158/1078-0432.CCR-07-5182
Details DOI PMID PMC WoS
-
2008 | Journal Article
Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma
Ziepert, M.; Schmits, R.; Truemper, L. H.; Pfreundschuh, M. & Loeffler, M. (2008)
Annals of Oncology, 19(4) pp. 752-762. DOI: https://doi.org/10.1093/annonc/mdm541
Details DOI PMID PMC WoS
-
2008 | Journal Article |
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M.; Engel, C.; Bloos, F.; Meier-Hellmann, A.; Ragaller, M.; Weiler, N. & Moerer, O. et al. (2008)
New England Journal of Medicine, 358(2) pp. 125-139. DOI: https://doi.org/10.1056/NEJMoa070716
Details DOI PMID PMC WoS